These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39354299)

  • 1. Global Metabolomics Using LC-MS for Clinical Applications.
    Skogvold HB; Sand ES; Elgstøen KBP
    Methods Mol Biol; 2025; 2855():23-39. PubMed ID: 39354299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging the Polar and Hydrophobic Metabolome in Single-Run Untargeted Liquid Chromatography-Mass Spectrometry Dried Blood Spot Metabolomics for Clinical Purposes.
    Skogvold HB; Sandås EM; Østeby A; Løkken C; Rootwelt H; Rønning PO; Wilson SR; Elgstøen KBP
    J Proteome Res; 2021 Aug; 20(8):4010-4021. PubMed ID: 34296888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations.
    Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H
    Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting lysosomal storage disorders by glycomic profiling using liquid chromatography mass spectrometry.
    Mak J; Cowan TM
    Mol Genet Metab; 2021; 134(1-2):43-52. PubMed ID: 34474962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
    Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
    Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS Untargeted Protocol for the Analysis of Wine.
    Arapitsas P; Mattivi F
    Methods Mol Biol; 2018; 1738():225-235. PubMed ID: 29654594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New and vintage solutions to enhance the plasma metabolome coverage by LC-ESI-MS untargeted metabolomics: the not-so-simple process of method performance evaluation.
    Tulipani S; Mora-Cubillos X; Jáuregui O; Llorach R; García-Fuentes E; Tinahones FJ; Andres-Lacueva C
    Anal Chem; 2015 Mar; 87(5):2639-47. PubMed ID: 25642801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MS
    Folberth J; Begemann K; Jöhren O; Schwaninger M; Othman A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1145():122105. PubMed ID: 32305706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotope Labeling-Assisted Evaluation of Hydrophilic and Hydrophobic Liquid Chromatograph-Mass Spectrometry for Metabolomics Profiling.
    Xie B; Wang Y; Jones DR; Dey KK; Wang X; Li Y; Cho JH; Shaw TI; Tan H; Peng J
    Anal Chem; 2018 Jul; 90(14):8538-8545. PubMed ID: 29883117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substances.
    Manier SK; Keller A; Schäper J; Meyer MR
    Sci Rep; 2019 Feb; 9(1):2741. PubMed ID: 30808896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Untargeted and Targeted Circadian Metabolomics Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) and Flow Injection-Electrospray Ionization-Tandem Mass Spectrometry (FIA-ESI-MS/MS).
    Artati A; Prehn C; Lutter D; Dyar KA
    Methods Mol Biol; 2022; 2482():311-327. PubMed ID: 35610436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
    Boonchaisri S; Rochfort S; Stevenson T; Dias DA
    Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
    Li J; Liu D; Cui M; Wei Z
    J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Long-Term Storage on the Biobanked Neonatal Dried Blood Spot Metabolome.
    Ottosson F; Russo F; Abrahamsson A; MacSween N; Courraud J; Nielsen ZK; Hougaard DM; Cohen AS; Ernst M
    J Am Soc Mass Spectrom; 2023 Apr; 34(4):685-694. PubMed ID: 36913955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Offline Two-Dimensional Liquid Chromatography-Mass Spectrometry for Deep Annotation of the Fecal Metabolome Following Fecal Microbiota Transplantation.
    Anderson BG; Raskind A; Hissong R; Dougherty MK; McGill SK; Gulati AS; Theriot CM; Kennedy RT; Evans CR
    J Proteome Res; 2024 Jun; 23(6):2000-2012. PubMed ID: 38752739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.
    Boudah S; Olivier MF; Aros-Calt S; Oliveira L; Fenaille F; Tabet JC; Junot C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():34-47. PubMed ID: 24815365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a SWATH capillary LC-MS/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma.
    Xiao J; Shi J; Li R; Her L; Wang X; Li J; Sorensen MJ; Bhatt-Mehta V; Zhu HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122865. PubMed ID: 34365292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMBL-MCF 2.0: an LC-MS/MS method and corresponding library for high-confidence targeted and untargeted metabolomics using low-adsorption HILIC chromatography.
    Dekina S; Alexandrov T; Drotleff B
    Metabolomics; 2024 Oct; 20(6):114. PubMed ID: 39397202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementing reversed-phase selectivity with porous graphitized carbon to increase the metabolome coverage in an on-line two-dimensional LC-MS setup for metabolomics.
    Ortmayr K; Hann S; Koellensperger G
    Analyst; 2015 May; 140(10):3465-73. PubMed ID: 25824707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and Challenges in Quantifying Carbonyl-Metabolomic Phenomes with LC-MS/MS.
    Sun Y; Tang H; Wang Y
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.